Detection of Human Immunodeficiency Virus Type 1 (HIV-1) A/AE Circulating Recombinant Form (CRF) in India: Possible Implications.
BACKGROUND
Rapidly evolving viruses such as human immunodeficiency virus (HIV-1) develop marked sequence differences in their genome over the course of an epidemic and in individuals infected for longer duration. This is because of the error prone reverse transcriptase (RT), which rapidly incorporates mutations resulting in genomic diversity, altered cell tropism, immune escape, and variable resistance to antiretroviral drugs. As a result, radically different genomic combinations may be generated in individuals infected by genetically diverse viruses that have mosaic genomes.


METHODS
Whole blood sample was collected from 25 HIV-1 infected patients. Chromosomal DNA was isolated from the patient's peripheral blood mononuclear cells (PBMCs). Full-length gag gene (~1.5 kb) was amplified. PCR products were subjected to direct automated sequencing. For identification of recombinants Simplot version 2.5 was used.


RESULTS
Out of 25 gag genes that were sequenced, the gene amplified from a 29 years old HIV-1 seropositive male revealed a putative recombinant sequence. This sequence showed maximum homology with HIV-1 subtype A. Simplot analysis revealed the sequence to be a likely recombinant with the following composition: Initial stretch of 1 to 200 nucleotides representing AE circulating recombinant form (CRF), 201 to 440 nucleotides representing HIV-1 subtype A, 441 to 660 nucleotides representing AE CRF again, 661 to 700 nucleotides representing HIV-1 subtype A and the remaining stretch of the nucleotides from 701 to 1076 representing AE CRF.


CONCLUSIONS
We document a putative HIV-1 subtype A/ AE CRF. It is important to monitor various CRFs that are being generated and horizontally spread in the community. This has significant implications for development of candidate vaccine for India.
Reader (Microbiology and Pathology) AFMC, Pune 411040.
R M
RM
Gupta
Professor & Head, AFMC, Pune 411040.
P
P
Seth
Senior Research Fellow, (Department of Microbiology), AIIMS, New Delhi 110029.
Vvsp
V
Prasad
Classified Specialist (Pathology and Microbiology), DRDE, Gwalior.
A K
AK
Sahni
Senior Advisor, (Pathology and Microbiology), Command Hospital (WC), Chandimandir.
J
J
Jena
CRF (Circulating Recombinant Form); HIV-1
Science. 1988 Nov 25;242(4882):1168-71
2460924
J Virol. 2000 Jan;74(1):363-70
10590125
Nature. 1995 Jan 12;373(6510):123-6
7816094
Lancet Infect Dis. 2003 Jan;3(1):22-7
12505029
MMWR Recomm Rep. 1992 Dec 18;41(RR-17):1-19
1361652
AIDS Res Hum Retroviruses. 2002 Nov 1;18(16):1219-27
12494921
J Virol. 1999 Jan;73(1):152-60
9847317
AIDS Res Hum Retroviruses. 1996 May 1;12(7):641-3
8743090
AIDS Res Hum Retroviruses. 1999 Jul 1;15(10):941-4
10408731
AIDS. 1993 Jun;7(6):769-80
8363755
AIDS Res Hum Retroviruses. 1996 Oct 10;12(15):1435-41
8893051
AIDS. 2000;14 Suppl 3:S31-44
11086847
Int J STD AIDS. 2002 Feb;13(2):115-8
11839166
Proc Natl Acad Sci U S A. 1990 Feb;87(4):1556-60
2304918
J Virol. 1996 Oct;70(10):7013-29
8794346
Nature. 1995 Jan 12;373(6510):117-22
7529365
JAMA. 1996 Jan 17;275(3):210-6
8604174
Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
9396791
Lancet Infect Dis. 2002 Aug;2(8):461-71
12150845